Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Trending Desk

Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'

As weight-loss drugs gain popularity globally, Nithin Kamath has raised questions about why India is not seeing the same level of enthusiasm for GLP-1 medications, even as prices become more affordable. His comments sparked a wider discussion after Biocon chief Kiran Mazumdar-Shaw weighed in, urging caution and emphasizing that diet and exercise should remain the first choice for people who are not clinically obese or diabetic.

ALSO READ: Weather tomorrow June 28

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.